Recursion Pharmaceuticals
RXRX
#3840
Rank
HK$19.86 B
Marketcap
HK$50.84
Share price
2.03%
Change (1 day)
-36.65%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2024 (TTM): -HK$2.99 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are HK$64.6 Million. In 2023 the company made an earning of -HK$2.59 Billion a decrease over its 2022 earnings that were of -HK$1.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$2.99 Billion15.32%
2023 -HK$2.59 Billion38.68%
2022 -HK$1.87 Billion30.46%
2021 -HK$1.43 Billion114.28%
2020 -HK$0.67 Billion